Skip to main content
. Author manuscript; available in PMC: 2023 Oct 12.
Published in final edited form as: Int J Cancer. 2021 Jan 9;148(10):2571–2578. doi: 10.1002/ijc.33454

Figure 2:

Figure 2:

Cumulative positivity rate of HPV and VIA screening compared to the cumulative rate of CIN2+ over the study’s duration. The positivity rate for each was calculated by dividing the total number who screened positive or were diagnosed by CIN2+ by the total number who had completed Visit 1 by the date specified. Significant dates corresponding to changes in clinic personnel or physician training are indicated.